Novacyt outlines strong new product pipeline
There was some relief for shareholders in specialist diagnostics group Novacyt (NCYT:AIM) on Wednesday after its shares gained 6% to 725p following an update on its research and development (R&D) activities. The shares have dropped...
24 February 2021
